Bosutinib Tablets provides a prescription savings and copay assistance program designed to help eligible commercially insured patients reduce out-of-pocket costs for bosutinib in the United States. The program is connected to Alembic Pharmaceuticals and includes clear eligibility rules, terms, and conditions for use. Bosutinib is a targeted treatment used in Philadelphia chromosome-positive chronic myeloid leukemia, making this platform a support resource for patients and caregivers looking for access and affordability options for this specialty medication.